van den Berg W B, van de Loo F A, Zwarts W A, Otterness I G
Department of Rheumatology, University Hospital St Radboud, Nijmegen, The Netherlands.
Ann Rheum Dis. 1988 Oct;47(10):855-63. doi: 10.1136/ard.47.10.855.
Murine recombinant interleukin 1 (IL1) was tested for its ability to affect intact murine articular cartilage. IL1 caused enhanced proteoglycan degradation and severe inhibition of chondrocyte synthetic function at a concentration of 3 U/ml (100 pg/ml). Inhibition of proteoglycan synthesis appeared to be delayed in onset but occurred consistently after 24 hours. Pulse chase experiments made it clear that proteoglycan degradation and inhibition of proteoglycan synthesis are two distinct actions of IL1. No indications were obtained for selective degradation of either newly synthesised or processed proteoglycan. Moreover, chondrocyte synthetic activity appeared to be inhibited uniformly throughout the cartilage matrix, i.e., no evidence was found for selective suppression of cells in certain regions. IL1 uptake measurement in the cartilage, using [125I]IL1, yielded a partition coefficient far below 1, and autoradiography demonstrated a faint but even distribution within the cartilage matrix. The coordinated induction of enhanced breakdown of proteoglycan and inhibition of proteoglycan synthesis, with such low concentrations of IL1 reaching the chondrocytes, underlines the impressive destructive potential of IL1.
对小鼠重组白细胞介素1(IL1)影响完整小鼠关节软骨的能力进行了测试。在浓度为3 U/ml(100 pg/ml)时,IL1导致蛋白聚糖降解增强,并严重抑制软骨细胞的合成功能。蛋白聚糖合成的抑制似乎起始延迟,但在24小时后持续发生。脉冲追踪实验表明,蛋白聚糖降解和蛋白聚糖合成抑制是IL1的两种不同作用。未发现新合成或加工的蛋白聚糖有选择性降解的迹象。此外,软骨细胞的合成活性似乎在整个软骨基质中均受到均匀抑制,即未发现某些区域的细胞有选择性抑制的证据。使用[125I]IL1对软骨中的IL1摄取进行测量,得到的分配系数远低于1,放射自显影显示在软骨基质内分布微弱但均匀。如此低浓度的IL1到达软骨细胞时,蛋白聚糖分解增强和蛋白聚糖合成抑制的协同诱导突出了IL1令人印象深刻的破坏潜力。